Yes. It will be a voluntary system, which means that at the clinic level, there will be a choice made by MS clinics about whether they will participate. At the patient level, there will also be a decision about whether they would want their anonymous information—so no personal identifiers—included in the national system. Of course, that is the way we operate in this country. We provide free consent to individuals as to whether they wish to participate in these types of ventures or not.
There's a huge interest when we look around the world and in Canada among people living with various neurological conditions, not just with MS, about being part of these types of monitoring systems, because they understand the benefit not only to themselves but also to Canadians at large. So we're quite confident that once patients with MS understand what this is, understand their right not to participate or their right to stop their participation at any time, they will be very receptive to participation in the monitoring system.
If I have just two more seconds, I'll say that when I talked about the national population health study of neurological conditions, one of the major parts of that study is talking to patients. One of the major advantages of this study will be that it's the first time we're learning directly from talking to patients about their experiences with neurological conditions, and they love participating in that part of the study.